一种从源头彻底解决组胺的全新产品——喜讯无组胺泰乐菌素
文摘
财经
2024-09-19 21:18
山东
摘要:欧洲药品管理局(EMA)严格要求厂商对发酵产品生产过程引入组胺的风险把控,多维医药集团根据法规要求,以保障产品质量为基本准则,动物及人类安全为最终目标,成功研制喜讯无组胺泰乐菌素并顺利上市达产。
参考文献
[1]Public Hlealth Risks of Histamine and other Biogenic Amines from Fish and Fishery Products.
JOINT FAO/WHO EXPERT MEETING,FAO Headquarters. Rome Italy. 23-27 July,2012[Z].
[2]Procedure under Article 5(3) of Regulation EC(No)726/2004.Procedure no:EMEA/H/A-5(3)/1468.April 10,2018[Z].
[3]CVM Passes sment report regarding the request for an opinion under Article30 (3)of Regulation (EC) No. 726/2004. Procedure no: EMEA/V/A/128.November 08,2018[Z].